Plethico Pharmaceutical is looking at trimming its Contract Research and Manufacturing Services (CRAMS) business as low margins are being further squeezed out due to higher inflation and surging crude oil prices.
Economic Times
Monday 30 June 2008
Plethico plans to cut CMO business
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment